Nonesterified Fatty Acids and Hospitalizations Among Older Adults: The Cardiovascular Health Study
- PMID: 32914181
- PMCID: PMC8489431
- DOI: 10.1093/gerona/glaa228
Nonesterified Fatty Acids and Hospitalizations Among Older Adults: The Cardiovascular Health Study
Abstract
Background: We sought to determine associations between total serum concentrations of nonesterified fatty acids (NEFAs) and incident total and cause-specific hospitalizations in a community-living cohort of older adults.
Methods: We included 4715 participants in the Cardiovascular Health Study who had fasting total serum NEFA measured at the 1992/1993 clinic visit and were followed for a median of 12 years. We identified all inpatient admissions requiring at least an overnight hospitalization and used primary diagnostic codes to categorize cause-specific hospitalizations. We used Cox proportional hazards regression models to determine associations with time-to-first hospitalization and Poisson regression for the rate ratios (RRs) of hospitalizations and days hospitalized.
Results: We identified 21 339 hospitalizations during follow-up. In fully adjusted models, higher total NEFAs were significantly associated with higher risk of incident hospitalization (hazard ratio [HR] per SD [0.2 mEq/L] = 1.07, 95% confidence interval [CI] = 1.03-1.10, p < .001), number of hospitalizations (RR per SD = 1.04, 95% CI = 1.01-1.07, p = .01), and total number of days hospitalized (RR per SD = 1.06, 95% CI = 1.01-1.10, p = .01). Among hospitalization subtypes, higher NEFA was associated with higher likelihood of mental, neurologic, respiratory, and musculoskeletal causes of hospitalization. Among specific causes of hospitalization, higher NEFA was associated with diabetes, pneumonia, and gastrointestinal hemorrhage.
Conclusions: Higher fasting total serum NEFAs are associated with a broad array of causes of hospitalization among older adults. While some of these were expected, our results illustrate a possible utility of NEFAs as biomarkers for risk of hospitalization, and total days hospitalized, in older adults. Further research is needed to determine whether interventions based on NEFAs might be feasible.
Keywords: Diabetes; Mental; Metabolism; Musculoskeletal; Pneumonia.
© The Author(s) 2020. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
The Associations of Individual and Subclasses of Nonesterified Fatty Acids With Disability, and Mobility Limitation in Older Adults: The Cardiovascular Health Study.J Gerontol A Biol Sci Med Sci. 2023 Jul 8;78(7):1155-1163. doi: 10.1093/gerona/glac206. J Gerontol A Biol Sci Med Sci. 2023. PMID: 36156076 Free PMC article.
-
Serum Nonesterified Fatty Acids and Incident Stroke: The CHS.J Am Heart Assoc. 2021 Nov 16;10(22):e022725. doi: 10.1161/JAHA.121.022725. Epub 2021 Nov 10. J Am Heart Assoc. 2021. PMID: 34755529 Free PMC article.
-
Nonesterified fatty acids and cardiovascular mortality in elderly men with CKD.Clin J Am Soc Nephrol. 2015 Apr 7;10(4):584-91. doi: 10.2215/CJN.08830914. Epub 2015 Jan 30. Clin J Am Soc Nephrol. 2015. PMID: 25637632 Free PMC article.
-
Associations of Serum Nonesterified Fatty Acids With Coronary Heart Disease Mortality and Nonfatal Myocardial Infarction: The CHS (Cardiovascular Health Study) Cohort.J Am Heart Assoc. 2021 Mar 16;10(6):e019135. doi: 10.1161/JAHA.120.019135. Epub 2021 Mar 8. J Am Heart Assoc. 2021. PMID: 33682438 Free PMC article.
-
The potential of circulating nonesterified fatty acids and sphingolipids in the biological understanding of cognitive decline and dementia.Curr Opin Lipidol. 2025 Feb 1;36(1):27-37. doi: 10.1097/MOL.0000000000000968. Epub 2024 Dec 6. Curr Opin Lipidol. 2025. PMID: 39641159 Review.
Cited by
-
The determinants of fasting and post-load non-esterified fatty acids in older adults: The cardiovascular health study.Metabol Open. 2023 Oct 23;20:100261. doi: 10.1016/j.metop.2023.100261. eCollection 2023 Dec. Metabol Open. 2023. PMID: 38115866 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
- U01 HL130114/HL/NHLBI NIH HHS/United States
- N01 HC085086/HC/NHLBI NIH HHS/United States
- N01HC55222/HL/NHLBI NIH HHS/United States
- HHSN268200800007C/HL/NHLBI NIH HHS/United States
- HHSN268201800001C/HL/NHLBI NIH HHS/United States
- U01 HL080295/HL/NHLBI NIH HHS/United States
- N01 HC085082/HC/NHLBI NIH HHS/United States
- HHSN268201200036C/HL/NHLBI NIH HHS/United States
- N01HC85079/HL/NHLBI NIH HHS/United States
- R01 AG053325/AG/NIA NIH HHS/United States
- N01HC85083/HL/NHLBI NIH HHS/United States
- N01 HC085080/HC/NHLBI NIH HHS/United States
- N01HC85081/HL/NHLBI NIH HHS/United States
- R01 AG023629/AG/NIA NIH HHS/United States